Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

Asia Pacific Thyroid cancer Market by Treatment (surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs) by End user(Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

ID: 2264 | Pages: 140 | May 2017 | Region: Asia Pacific


Asia Pacific market for Thyroid cancer was USD 29.47 million in 2016. Thyroid cancer market is expected to grow at a CAGR of 30.16% to reach USD 110.08 million by 2021. Thyroid cancer is basically treated by surgery and radiotherapy. Chemotherapy has fewer roles in the treatment. Doxorubicin is said to be used as an off-label drug for treating plastic thyroid cancer patients. In same way some other off-name medications, for example, carboplatin and cisplatin are used, however response rates have come down because of them. It can be concluded that Asia Pacific Thyroid Cancer Market is expected to have high growth rate.

Asia Pacific Thyroid Cancer Market is strong, because it consists of 27 molecules which are in different stages of development. There are four molecules in Pre-registration (1) and Phase III (3). These drugs mostly get approved in the next 7 years.  XL184, Zactima and Zybrestat have been granted orphan drug status by the FDA.

Once above molecules get approved, it will Intensify competition in market which in turn results in substantial growth in market. Current competition in Asia Pacific Thyroid Cancer Market is very less. Some effective treatments like surgery exist and chemotherapy drugs can be used. Companies such as Doxorubicin which aim at managing conditions are prone to get larger success in future.

Asia Pacific Thyroid Cancer Market is segmented on the basis of End User and Treatment broadly. On the basis of Treatment, market for thyroid cancer can be segmented into surgery, iodine therapy, External radiotherapy, Thyroxin treatment, chemotherapy, Drugs. Furthermore, Chemotherapy can be segmented into Cisplatin and Doxorubicin. Drugs are segmented into two in Asia Pacific Thyroid Cancer Market. They are Levothyroxine and Radioiodine. On the basis of End user, market for Asia Pacific thyroid cancer can be segmented into Hospital, Oncology centers, Hospital Pharmacies and Retail Pharmacies.

The major key players of Asia Pacific Thyroid Cancer Market are App pharmaceuticals llc, Bristol Myers co., Abbott laboratories, Baxter International Inc., Mylan pharmaceuticals Inc., Alara Pharmaceutical Corporation, Teva parenteral medicines Inc., and Jerome Stevens Pharmaceuticals Inc.,

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Treatment                                                  

                                5.1.1 Introduction                                           

                                5.1.2 Surgery                                     

                                5.1.3 Iodine Theraphy                                   

                                5.1.4 External radiotherapy                                        

                                5.1.5 Thyroxine treatment                                          

                                5.1.6  chemotherapy                                     

                                5.1.7 Drugs                                         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.9  Market Attractiveness Analysis, By Treatment                                       

                                5.1.10 Market Share Analysis, By Treatment                                       

                5.2 End User      

                                5.2.1 Introduction                                           

                                5.2.2 Hospital                                    

                                5.2.3 Oncology centers                                 

                                5.2.4 Hospital Pharmacies                                            

                                5.2.5 Retail Pharmacies                                 

                                5.2.6 Y-o-Y Growth Analysis, By End User                                             

                                5.2.7 Market Attractiveness Analysis, By End User                                           

                                5.2.8 Market Share Analysis, By End User                                             

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Treatment                     

                                                6.1.3.3 By End User                        

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Treatment                     

                                                6.1.4.3 By End User                        

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Treatment                     

                                                6.1.5.3 By End User                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Baxter International Inc                                                        

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Mylan pharmaceuticals Inc                                                  

                8.3 Alara Pharmaceutical Corporation                                                    

                8.4  Bristol Myers co                                                       

                8.5  Abbott laboratories                                                               

                8.6 Teva parenteral medicines Inc                                                           

                8.7 App pharmaceuticals llc                                                         

                8.8  Jerome Stevens Pharmaceuticals Inc                                                             

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  2. Asia Pacific Surgery Market By Region, From 2016 2021 ( USD Million )
  3. Asia Pacific Iodine Theraphy Market By Region, From 2016 2021 ( USD Million )
  4. Asia Pacific External radiotherapy Market By Region, From 2016 2021 ( USD Million )
  5. Asia Pacific Thyroxine treatment Market By Region, From 2016 2021 ( USD Million )
  6. Asia Pacific chemotherapy Market By Region, From 2016 2021 ( USD Million )
  7. Asia Pacific Drugs Market By Region, From 2016 2021 ( USD Million )
  8. Asia Pacific Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
  9. Asia Pacific Hospitals Market By Region, From 2016 2021 ( USD Million )
  10. Asia Pacific Oncology Centers Market By Region, From 2016 2021 ( USD Million )
  11. Asia Pacific Hospital Pharmacies Market By Region, From 2016 2021 ( USD Million )
  12. Asia Pacific Retail Pharmacies Market By Region, From 2016 2021 ( USD Million )
  13. Japan Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  14. Japan Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
  15. China Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  16. China Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
  17. India Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  18. India Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
  19. Australia Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  20. Australia Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
  21. South Korea Thyroid Cancer Market By Treatment, From 2016 2021 ( USD Million )
  22. South Korea Thyroid Cancer Market By  End User, From 2016 2021 ( USD Million )
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.